Adenomyosis & Endometriosis Keep Coming Back? Chronic Inflammation & Internal Scar Tissue Are the Real Root Cause

Aug 4

4 min read

Women living with adenomyosis and endometriosis often share the same frustrating confusion:

Painkillers, hormonal medication, intrauterine devices, and injectable treatments can suppress symptoms temporarily. But once you stop these interventions, painful periods, prolonged spotting, pelvic adhesions, and tissue lesions inevitably return.

The core reason most chronic gynecological conditions recur is not insufficient hormone levels or unmanaged pain. It lies in unresolved chronic inflammation and fibrotic scar tissue trapped deep inside your body.

Why Gynecological Conditions Worsen & Recur After Age 27

Every metabolic, repair, and detoxification process in the human body relies entirely on enzymes.

The human body produces roughly 3,000 unique enzymes that power over 7,000 distinct biological reactions.

Simply put: without enzymes, your body loses its self-repair capacity entirely.

Endogenous enzyme production begins to decline gradually starting at age 27, with a sharp, steep drop after 40.

This perfectly aligns with the typical progression of women’s reproductive health struggles:

Mild menstrual cramping in twenties
Endometrial hyperplasia and ovarian cysts emerging in thirties
Widespread adenomyosis, endometriosis, uterine fibroids, and breast nodules developing after 40

The chain reaction follows this exact sequence:

Enzyme deficiency → unprocessed inflammation → trapped stagnant blood → unbroken scar tissue → recurring, persistent lesions

Conventional hormonal interventions only address surface-level hormone fluctuations.

Systemic proteolytic enzymes target the underlying terrain where lesions grow and thrive.

Why Anti-Inflammatory Drugs & Hormones Fail to Resolve Pelvic Chronic Inflammation

Many women live with persistent low-grade pelvic inflammation marked by constant dull pelvic ache, deep dyspareunia, heavy menstrual pressure, adhesion tugging sensations, and mid-cycle stabbing pain.

This chronic inflammation is non-bacterial; it stems from repeated endometrial bleeding, accumulated immune waste, and tissue damage that creates sustained sterile inflammatory responses.

Conventional pain relievers and NSAIDs work by broadly blocking all inflammatory signaling pathways in the body.

Long-term use suppresses healthy immune function, irritates the gastrointestinal tract, and creates extra metabolic burden for the liver and kidneys. These drugs only mask pain temporarily and cannot clear embedded immune debris or fibrotic scar tissue deep within the pelvis.

Systemic proteolytic enzymes deliver selective, targeted anti-inflammatory action:

They break down only excess inflammatory immune complexes, stagnant blood waste, necrotic tissue remnants, and fibrous adhesion bands.

They preserve healthy immune function, create no organ toxicity, and do not disrupt natural bodily processes.

This makes them one of the safest, most long-acting natural approaches for persistent pelvic inflammation.

The Truth: Adenomyosis, Endometriosis & Chocolate Cysts Are All Pelvic Fibrotic Scar Disorders

Most people do not realize that ectopic lesions, thickened uterine muscle walls, pelvic adhesions, chocolate cyst linings, and hyperplastic nodules all develop as pathological scar tissue formed by repeated inflammation and internal bleeding.

Endometriosis: Ectopic endometrial tissue bleeds monthly, forming adhesions, pooled old blood, and thick fibrous encapsulation
Adenomyosis: Endometrial tissue invades the uterine muscle wall; tiny repeated monthly bleeds harden and thicken the myometrium into fibrotic tissue
Chocolate cysts: Stagnant menstrual blood gets locked inside fibrous tissue layers, thickening over time
Chronic pelvic inflammatory sequelae: Extensive fibrous adhesion bands bind pelvic organs together

Hormonal treatments, IUDs, and injections only suppress endometrial bleeding.

They cannot dissolve existing fibrotic scar tissue — this is the definitive reason symptoms rebound once treatment stops.

Systemic proteolytic enzymes are one of the few natural compounds capable of gradually breaking down, softening, and metabolizing pathological fibrous scar tissue inside the body.

Consistent, adequate supplementation delivers these tangible supportive effects:

Loosen restrictive pelvic adhesion bands
Metabolize micro-hematomas embedded in uterine muscle
Soften stiff, enlarged fibrotic uterine walls
Reduce buildup of stagnant menstrual debris
Lower lesion tissue activity

This is the foundational, core layer of natural support for adenomyosis and endometriosis management.

Improve Blood Circulation & Clear Stagnant Blood to Eliminate Lesion Fuel

Women with adenomyosis and endometriosis almost universally experience sluggish menstrual flow, pelvic blood stagnation, thick viscous blood, and slowed systemic metabolism.

Overburdened liver function leaves cellular waste, dead tissue fragments, and stagnant menstrual debris trapped in the pelvic cavity long-term. This accumulated waste continuously fuels inflammation and lesion proliferation.

Systemic proteolytic enzymes deliver three key circulatory benefits:

Reduce whole-blood viscosity to restore healthy pelvic microcirculation

Accelerate clearance of residual stagnant menstrual debris each cycle

Lower detox strain placed on the liver

Boost immune cell waste-clearing capacity

In short: clearing stagnant, waste-filled pelvic blood removes the nutrient-rich environment that allows lesions to regrow repeatedly.

Mitigate Estrogen Dominance to Restore Balanced Endocrine Function

The term Estrogen Dominance, coined by Dr. John Lee, identifies the primary root driver behind all hyperplastic gynecological conditions.

When estrogen levels remain disproportionately high relative to progesterone, the endometrium over-proliferates — triggering polyps, fibroids, adenomyosis, endometriosis, and fibrocystic breast changes.

Modern high-sugar diets, heavily processed foods, and pervasive environmental xenoestrogens create widespread hormonal imbalance. Many women show normal lab hormone readings yet experience localized tissue-level excess estrogen stimulation.

When paired with complementary natural hormonal support, systemic proteolytic enzymes deliver these balancing benefits:

Lower baseline chronic systemic inflammation

Reduce excessive aromatase activity that converts adipose tissue into surplus estrogen

Help rebalance the estrogen-to-progesterone ratio

As inflammation fades, stagnant blood clears, and hormone ratios stabilize, lesion activity naturally slows and plateaus.

Why Conventional Medical Practices Rarely Recommend Enzyme Therapy

Systemic proteolytic enzyme therapy is a well-documented nutritional complementary support backed by decades of peer-reviewed research confirming its safety and therapeutic value.

However, it falls under the category of nutritional supplements, not pharmaceutical medication.

For this reason, it is rarely covered in standard clinical gynecology training or stocked in hospital pharmacies.

Pharmaceutical interventions deliver fast, acute symptom suppression.

Systemic enzyme therapy targets long-term tissue repair, root-cause waste clearance, and lasting relapse reduction.

For women who wish to avoid lifelong hormone dependence or repeated surgical procedures and instead stabilize adenomyosis and endometriosis by correcting underlying bodily terrain, proteolytic enzyme support is an indispensable foundational tool.